ARCHIVES

Move Starts To Strip Anticancer Drug Regulation From FDA After New Charges It Is Delaying INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 42 | October 15, 1976

Download PDF Visit The Full Archive

Related Articles

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003

In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review

November 3, 1978